Collaboration the only viable way to protect the pharma supply chain, warns GSK

© Khunaspix Dreamstime.

Pharmaceutical manufacturers and their supply chain partners need to improve their business continuity planning to deal with threats from terrorist attacks, political instability and unforeseen climate events, according to Stephen Mitchell, quality assurance and compliance manager at GlaxoSmithKline.

Dr Mitchell warned the Air Cargo News Life Sciences & Pharmaceuticals  Conference in London of the potential catastrophic impact of so-called “black swan” incidents.

“We’ve got to refocus on areas of potential vulnerability in the supply chain. If there’s a massive power failure or ...